Hyperglycemia and glucose variability are associated with worse survival in mechanically ventilated COVID-19 patients: the prospective Maastricht Intensive Care Covid Cohort
Among 232 mechanically ventilated COVID-19 patients, 21.1% had known diabetes mellitus, whereas 16.9% in wave 2 had unknown diabetes mellitus.
Changes in Lifestyle Habits in Individuals with Diabetes during the COVID-19 Pandemic: The ELSA-Brasil Cohort Study
The COVID-19 pandemic and society’s response to it may have constrained the ability of those with diabetes to achieve a healthy lifestyle.
9th Influenza Conference 2023
The Ninth ESWI Influenza Conference: Highlights
ESWI 2023: 10 key take home messages
International scientific community gathers in Valencia for the 9th ESWI Conference on Influenza, COVID-19, and RSV
Since it was established 30 years ago, the European Scientific Working Group on Influenza and other Acute Respiratory Viruses (ESWI) is hosting the 9TH ESWI Influenza Conference
ESWI Airborne: Burden of Disease
Burden of disease - Long-Covid and other post-infection syndromes
What do we know about long-Covid? In this captivating episode we listen to the personal and powerful account of how the lingering effects of Sars-CoV-2 has wreaked havoc in an otherwise healthy person.
Diagnosis of type 1 diabetes after SARS-CoV-2 infection: Researchers find possible correlation
Researchers at Helmholtz Munich and TU Dresden, in cooperation with the Kassenärztliche Vereinigung Bayern, have now investigated whether there is a temporal association between infection with the SARS-CoV-2 virus and the development of type 1 diabetes.
Association of COVID-19 Infection With Incident Diabetes
SARS-CoV-2 infection may lead to acute and chronic sequelae. Emerging evidence suggests a higher risk of diabetes after infection, but population-based evidence is still sparse.
IDF Diabetes Atlas 2022 Reports
In 2022, the annual Atlas took a deeper look into the impact of type 2 diabetes in indigenous peoples, type 1 diabetes across all age groups, COVID-19 among people with diabetes, and diabetes foot-related complications.
Vaccination of special-risk groups: A toolkit for pharmacists by the International Pharmaceutical Federation (FIP)
It summarises key information, practice guidelines and additional resources in a very practical manner. The Influenza Diabetes Community (IDC) has contributed to the chapter on people living with diabetes.
The biggest diabetes research stories of 2022
2022 has been a big year for diabetes research, filled with historic moments and world-firsts. Here we take a look back at some of the incredible progress Diabetes UK-funded scientists and diabetes researchers across the globe have been behind this year.
Risk of Type 1 Diabetes in Children is Not Increased after SARS-CoV-2 Infection: A Nationwide Prospective Study in Denmark
It has been hypothesized that SARS-CoV-2 infection in children can increase risk of developing type 1 diabetes.